Govindaraj Vijayakumar, Yaduvanshi Nirmala Singh, Krishnamachar Harish, Rao A Jagannadha
Horm Mol Biol Clin Investig. 2012 Apr;9(3):173-8. doi: 10.1515/hmbci-2011-0130.
Abstract Background: Thyroid-stimulating hormone receptor (TSHR) is one of the members of glycoprotein hormone receptor family; activation of TSHR by thyroid-stimulating hormone (TSH) regulates thyroid function, proliferation, and differentiation. The other family members of glycoprotein hormone receptors, such as leutinizing hormone receptor (LHR), human chorionic gonadotropin (hCG), and follicle-stimulating hormone (FSH) are known to be expressed in nonendocrine tissues including human breast cancer and regulate proliferation and differentiation. The involvement of thyroid hormones in the growth and differentiation of normal breast tissue is well documented. However, the presence of TSHR in breast cancer has not been demonstrated. The aim of the present study was to establish the expression pattern of TSHR along with transcription factors, such as octamer 4 (OCT4) and intracisternal A particle-promoted polypeptide (IPP) in human breast tumor.
For this study, patients with stages I-III breast cancers and adjacent noncancerous tissues were prospectively accrued and analyzed. We employed semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis to determine the expression levels of TSHR in normal and human breast cancer tissues.
The results indicated that a significant increase in TSHR expression was observed in tumor tissues compared to normal breast tissues. RT-PCR analysis of OCT4 and IPP also revealed a significant increase in breast tumor tissues over the controls.
To our knowledge, this is the first report demonstrating expression of TSHR and IPP in normal breast and breast tumors. The expression of TSHR, IPP, and OCT4 increased in the human breast tumor samples over the noncancer tissues. However, further studies are needed to establish an unequivocal role for TSHR in breast tumor progression.
摘要背景:促甲状腺激素受体(TSHR)是糖蛋白激素受体家族成员之一;促甲状腺激素(TSH)激活TSHR可调节甲状腺功能、增殖和分化。已知糖蛋白激素受体的其他家族成员,如促黄体生成素受体(LHR)、人绒毛膜促性腺激素(hCG)和促卵泡激素(FSH),在包括人类乳腺癌在内的非内分泌组织中表达,并调节增殖和分化。甲状腺激素参与正常乳腺组织的生长和分化已有充分记录。然而,乳腺癌中TSHR的存在尚未得到证实。本研究的目的是确定TSHR以及转录因子八聚体4(OCT4)和脑内A颗粒促进多肽(IPP)在人类乳腺肿瘤中的表达模式。
在本研究中,前瞻性收集并分析了I - III期乳腺癌患者及相邻的非癌组织。我们采用半定量逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析来确定正常和人类乳腺癌组织中TSHR的表达水平。
结果表明,与正常乳腺组织相比,肿瘤组织中TSHR表达显著增加。对OCT4和IPP的RT-PCR分析也显示,乳腺肿瘤组织中的表达显著高于对照组。
据我们所知,这是第一份证明TSHR和IPP在正常乳腺和乳腺肿瘤中表达的报告。在人类乳腺肿瘤样本中,TSHR、IPP和OCT4的表达高于非癌组织。然而,需要进一步研究以明确TSHR在乳腺肿瘤进展中的作用。